Broadly, his research interests include the neurobiology underlying drug use and abuse, with a focus on neuromodulatory G-protein coupled neurotransmitter receptors in the central and peripheral nervous system.Bruchas works to discover how GPCR receptor systems function in the context of addiction and treatment.He received his undergraduate degree in biology and PhD in pharmacology from Creighton University.
Events - Primer's event detection algorithm clusters and summarizes multiple documents describing real-world events.
Mentions - Mentions are snippets of text that map to a person.
Docs - The number of documents that match to a person in Primer's corpus of news articles.
Full tech explainer here.
To update Wikipedia with this information, visit the page for the subject above.
Washington University in St. Louis
A wireless device, demonstrated for the first time in mice, can be implanted in the brain and activated by the remote push of a button to deliver drugs, according to a study published today in the journal Cell. The implanted device, the width of a human hair, could one day help treat pain, depression, epilepsy and other neurological disorders in people by targeting therapies to specific brain circuits, say researchers. “This approach potentially could deliver therapies that are much more targeted but have fewer side effects,” said co-principal investigator Michael R. Bruchas, Ph.D., associate professor of anesthesiology and neurobiology at Washington University in a release. Currently, many medications have side effects because when administered, the drug interacts with other parts of the body that are not the intended target of the drug.